stella
beta
Recruiting
Back to Neuroblastoma Recurrent trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
St. Jude Children's Research Hospital, Memphis, Tennessee
View full record on ClinicalTrials.gov
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma — Stella